Given that chromatin remodeling and metabolic dysfunction are gaining considerable attention in cancer studies, future researches on the PWWP domains of Pdp3 and NSD3s may contribute to the design of new anti-cancer drugs. This evidence concerns the gene PDPR and cancer.